Dr. Samreen Munir, MD

Dr. Munir practices at Raritan Bay Medical Center in Perth Amboy, New Jersey, part of Hackensack Meridian Health.

Dr. Munir's NPI, 1871978114, was assigned on July 28, 2015. Dr. Munir holds Kentucky license 52915.

Dr. Munir's primary practice is Raritan Bay Medical Center, at 530 New Brunswick Ave, Perth Amboy, NJ 08861 in Middlesex County. The practice phone is (732) 324-5000. Dr. Munir also practices at Raritan Bay Medical Center, 531 New Brunswick Ave, Perth Amboy, NJ 08861.

Dr. Munir's primary practice is Raritan Bay Medical Center in Perth Amboy, New Jersey, part of Hackensack Meridian Health. Dr. Munir is also affiliated with Hackensack University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Munir to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Munir practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Munir's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Munir is licensed in Kentucky.

CMS data shows 271 Medicare services from Dr. Munir across 4 procedure codes in 2024, for 52 Medicare patients. Medicare paid $20,197 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Dr. Munir in 2024. The largest group is under 65, with 33 patients. 75% of them have anxiety, and 75% have bipolar disorder. 50% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Munir's median patient age at 38, with 36% women.

In 2024, Dr. Munir wrote 60 Medicare Part D claims for 24 patients. 87% of them were for generic drugs. CMS names the drug for 53 of them, across 3 drugs with 11 or more claims each, at $669 in total drug cost. In 2021, CMS named 294 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Munir for performance year 2024, reported as part of a group. Dr. Munir accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 17 general payments to Dr. Munir from 10 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $164.